太阳的免疫效应,维生素D只能解释一半:UV两条平行通路的拆分难题

Written by

in

Language

Evidence level: A

太阳照在皮肤上,同时启动了两套免疫程序:一套走维生素D(诱导抗菌肽 cathelicidin),一套根本不碰维生素D(诱导 β-defensin-2 和干扰素信号)。要搞清”天时”到底怎么影响人体,先得把这两条线剪开。

正文

在上一篇文章里,我们把”太阳周期→疾病流行”的因果链押在了维生素D这个中介变量上。但这里有一个被大多数人忽略的陷阱:紫外线(UV)对人体的免疫调节,从来不是维生素D一条单行道。它其实并行跑着两条通路——一条依赖维生素D,一条不依赖。不把它们拆开,任何”太阳效应”的归因都会算错账。

最干净的直接证据,来自皮肤科学的一对经典实验。2009 年 Gläser 团队发表在《Journal of Allergy and Clinical Immunology》的研究(PMID 19342087),把正常人角质细胞拿去照 UVB,再逐个测抗菌肽的表达。结果发现:β-defensin-2(HBD2)、β-defensin-3、核糖核酸酶 7、psoriasin 这几种抗菌肽,被 UVB 以剂量依赖的方式直接诱导上调——这个过程完全不经过维生素D;而另一个抗菌肽 cathelicidin(LL-37),则必须依赖维生素D受体的激活才会上调。换句话说,同一束紫外线,在同一个细胞里,同时点燃了两条互不相干的免疫通路。

这个”HBD2 不依赖、cathelicidin 依赖”的分离,后来被更精细的代谢实验坐实。后续研究用酮康唑阻断维生素D的活性形式(骨化三醇)合成后,cathelicidin 和 CYP24A1 的诱导被阻断,但 HBD2 的诱导反而被”解救”(de-repression)增强——说明维生素D代谢产物在角质细胞里甚至会对 HBD2 通路形成某种竞争性抑制。这是通路拆分的分子级铁证。

机制上,那条”非维生素D”通路走的是另一套信号。2013 年的一项研究(PMID 23281696)发现,UV 照射后的角质细胞会释放内源性配体(如热休克蛋白 HSP60/HSP70),通过 Toll 样受体 TLR2/TLR4 激活朗格汉斯细胞下游的 MAPK、NF-κB 和干扰素调节因子 3(IRF3)——这是一条典型的”损伤相关分子模式”驱动的先天免疫通路,与维生素D受体(VDR)毫无关系。

把视野拉高,这条双通路结构是理解整个领域争议的钥匙。2011 年《Nature Reviews Immunology》的权威综述(PMID 21852793)标题就点破了天机:“UV 调节免疫系统:不只是维生素D的效应”。它系统梳理了 UV 通过诱导调节性 T 细胞、改变树突状细胞与 T 细胞亚群组成、激活一氧化氮合酶(NOS)与血红素加氧酶(HO)代谢通路等多条不依赖维生素D的途径,来抑制自身免疫。2021 年 Razzaque 团队的综述(PMID 34329737)进一步把这条线索推到临床:在多发性硬化、1 型糖尿病这些”阳光保护”证据最硬的自身免疫病里,流行病学的保护效应,恰恰主要归因于维生素D之外的阳光通路。

那么,为什么这件事对”科学易学”这个项目如此重要?因为它直接决定了一个结论的成败:如果我们把”太阳周期影响健康”全部归功于维生素D,就会高估维生素D、也低估太阳。 2017 年一篇专门讨论”UV 与维生素D在感染季节性中作用”的综述(PMID 28078341)说得最透彻:UV 通过抗菌肽激活固有免疫(依赖维生素D),又通过光产物直接激活干扰素信号(不依赖维生素D),两条路可互补、可拮抗。这意味着,除非在同一个样本里把两条通路同时拆开测量,否则任何”太阳→疾病”的效应量估计都是两条路的混合体,无法归因。

这正是本主题的”待验证”核心:需要一个对照设计——一组补维生素D(只激活依赖通路)、一组做等剂量 UV 暴露(同时激活两条通路)、一组安慰剂(都不激活),再同步测免疫指标(抗菌肽、干扰素、T 调节细胞),用中介分析或孟德尔随机化去拆分”依赖通路贡献多少、非依赖通路贡献多少”。

证据与局限

已验证:
– UVB 同时诱导”维生素D依赖”(cathelicidin)与”非依赖”(HBD2/psoriasin)两套抗菌肽,且可被代谢抑制剂实验分离(PMID 19342087)。
– 非依赖通路存在独立机制:UV 诱导的 HSP 经 TLR2/4 激活 NF-κB/IRF3(PMID 23281696)。
– 综述层面确认”UV 免疫调节 ≠ 维生素D”,非依赖通路包括 Treg、树突细胞、NOS/HO 代谢(PMID 21852793、34329737)。

部分验证:
– 两条通路的相对贡献比例,在真实人群、真实太阳周期暴露下尚未被定量拆分——目前证据来自体外细胞实验与综述,缺大样本人体中介分析。

待验证:
– 对照设计(补维生素D vs 等剂量 UV vs 安慰剂)下,依赖/非依赖通路的贡献拆分。
– 非依赖通路的效应,是否同样存在纬度梯度与太阳周期调制(若存在,则”太阳→健康”有第二条第独立通路)。

相关阅读

证据等级: A
参考文献: PMID 34329737, PMID 19342087, PMID 21852793, PMID 23281696, PMID 28078341


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

The Immune Effect of the Sun: Vitamin D Explains Only Half The Challenge Of Splitting UV’S Two Parallel Pathways

Evidence level: A

When sunlight strikes the skin, it simultaneously initiates two distinct immune programs: one mediated by Vitamin D (inducing cathelicidin) and one independent of Vitamin D (inducing β-defensin-2 and interferon signaling). To clarify exactly how “heavenly timing” influences the human body, these two lines must first be disentangled.

Main Text

In the previous article, we posited a causal chain from “solar cycles → disease prevalence” mediated by Vitamin D. However, there is a trap largely overlooked by most: the immune modulation of ultraviolet (UV) radiation on the human body is never a single track via Vitamin D. Instead, it runs two parallel pathways—one dependent on Vitamin D and one independent. Without separating them, any attribution of a “solar effect” will result in accounting errors.

The cleanest direct evidence comes from a pair of classic experiments in dermatology. A 2009 study by the Gläser team published in the Journal of Allergy and Clinical Immunology (PMID 19342087) exposed normal human keratinocytes to UVB and subsequently measured the expression of antimicrobial peptides. The results revealed that β-defensin-2 (HBD2), β-defensin-3, ribonuclease 7, and psoriasin were directly upregulated in a dose-dependent manner by UVB—a process completely bypassing Vitamin D; whereas another antimicrobial peptide, cathelicidin (LL-37), required activation of the Vitamin D receptor to be upregulated. In other words, a single beam of UV radiation ignites two unrelated immune pathways within the same cell simultaneously.

This separation of “HBD2 independent, cathelicidin dependent” was later corroborated by more refined metabolic experiments. Subsequent studies using ketoconazole to block the synthesis of active Vitamin D forms (calcitriol) found that while the induction of cathelicidin and CYP24A1 was blocked, the induction of HBD2 was instead “de-repressed” and enhanced—indicating that Vitamin D metabolites in keratinocytes may even exert competitive inhibition on the HBD2 pathway. This constitutes molecular-level proof of pathway separation.

Mechanistically, the “non-Vitamin D” pathway follows a different signaling cascade. A 2013 study (PMID 23281696) found that UV-exposed keratinocytes release endogenous ligands (such as heat shock proteins HSP60/HSP70), which activate downstream MAPK, NF-κB, and interferon regulatory factor 3 (IRF3) in Langerhans cells via Toll-like receptors TLR2/TLR4. This represents a classic innate immune pathway driven by “damage-associated molecular patterns,” entirely unrelated to the Vitamin D receptor (VDR).

Broadening the perspective, this dual-pathway structure is the key to understanding the controversy across the entire field. A 2011 authoritative review in Nature Reviews Immunology (PMID 21852793) explicitly highlighted the core insight in its title: “UV Regulation of the Immune System: Not Just a Vitamin D Effect.” It systematically organized how UV inhibits autoimmunity through multiple pathways independent of Vitamin D, including inducing regulatory T cells, altering the composition of dendritic cells and T-cell subsets, and activating NOS and HO metabolic pathways. Razzaque’s team further advanced this line of inquiry to clinical settings in their 2021 review (PMID 34329737); in autoimmune diseases with the strongest epidemiological evidence for “sun protection,” such as multiple sclerosis and type 1 diabetes, the protective effect is primarily attributed to sunlight pathways outside of Vitamin D.

So why is this critical for the “Scientific Yijing” project? Because it directly determines the success or failure of a conclusion: if we attribute all “solar cycle impacts on health” solely to Vitamin D, we will overestimate Vitamin D and underestimate the Sun. A 2017 review specifically discussing “the roles of UV and Vitamin D in infection seasonality” (PMID 28078341) provides the clearest explanation: UV activates innate immunity via antimicrobial peptides (Vitamin D-dependent) and directly activates interferon signaling via photoproducts (non-Vitamin D-dependent). The two pathways are complementary or antagonistic. Consequently, unless both pathways are measured simultaneously in the same sample, any estimation of effect size for “Sun → Disease” is a mixture of both pathways and cannot be attributed specifically.

This is the core “to-be-verified” aspect of this topic: a control design is needed—a group supplemented with Vitamin D (activating only the dependent pathway), a group exposed to equivalent-dose UV (activating both pathways simultaneously), and a placebo group (neither activated). Concurrent immune markers (antimicrobial peptides, interferons, T-regulatory cells) should be measured, followed by mediation analysis or Mendelian randomization to split the contributions of the “dependent pathway” versus the “non-dependent pathway.”

Evidence and Limitations

Verified:
– UVB simultaneously induces two sets of antimicrobial peptides: “Vitamin D-dependent” (cathelicidin) and “non-dependent” (HBD2/psoriasin), which can be separated via metabolic inhibitor experiments (PMID 19342087).
– The non-dependent pathway possesses an independent mechanism: UV-induced HSPs activate NF-κB/IRF3 via TLR2/4 (PMID 23281696).
– Reviews confirm “UV immune modulation ≠ Vitamin D,” with non-dependent pathways including Tregs, dendritic cells, and NOS/HO metabolism (PMID 21852793, 34329737).

Partially Verified:
– The relative contribution proportions of the two pathways have not yet been quantitatively split in real populations under real solar cycle exposure—current evidence derives from in vitro cell experiments and reviews, lacking large-sample human mediation analysis.

To Be Verified:
– Contribution splitting of dependent/non-dependent pathways under a control design (Vitamin D supplementation vs. equivalent-dose UV vs. placebo).
– Whether the effect of the non-dependent pathway also exhibits latitudinal gradients and solar cycle modulation (if so, there is a second independent pathway for “Sun → Health”).

Related Reading

Evidence Level: A
References: PMID 34329737, PMID 19342087, PMID 21852793, PMID 23281696, PMID 28078341


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *